Investec Maintains Buy on Astral Ltd, ₹1,710 Target on DSS Acquisition
Investec has maintained a Buy rating on Astral Ltd with a target price of ₹1,710, viewing the acquisition of a 60% stake in DSS for ₹39.11 crore as a strategic move to deepen backward integration in specialty chemicals, drive cost efficiencies, and build a scalable new growth vertical, while noting that revenue ramp-up visibility from DSS remains awaited.
*this image is generated using AI for illustrative purposes only.
Astral Limited 's wholly owned subsidiary, Astral Chemie Limited, has entered into definitive agreements to acquire a 60% partnership interest in Differentiated and Sustainable Solutions LLP (DSS) for an aggregate consideration of ₹39.11 crore. The transaction, expected to be completed on or before August 31, 2026, will make DSS a subsidiary of Astral Chemie Limited and a step-down subsidiary of Astral Limited. This strategic move is aimed at strengthening Astral's backward integration in key raw materials and expanding its footprint in the specialty chemicals segment.
Analyst View
Investec has maintained a Buy rating on Astral Ltd with a target price of ₹1,710, citing the acquisition of a 60% stake in DSS — a specialty chemicals and advanced materials company — as a strategic move to deepen backward integration, drive cost efficiencies, and create a scalable new growth vertical. The brokerage also highlighted upside risks to estimates stemming from CPVC integration benefits and DSS expansion potential, though it noted that revenue ramp-up visibility remains awaited.
Acquisition Overview
The acquisition involves a cash consideration of ₹39.11 crore for a 60% stake in DSS, an entity incorporated on December 28, 2015. DSS is engaged in developing technologies for specialty chemicals and materials used in electronics, aerospace, renewable energies, and infrastructure. The deal is not a related party transaction and does not require specific governmental or regulatory approvals.
Financials and Operations
DSS operates a manufacturing facility at E-7, Vilayat GIDC, Dist. Bharuch-392012, Gujarat, with an annual capacity of 5,200 M.T. The company has reported the following turnover figures over the past three years:
| Period | Turnover (₹ in Millions) |
|---|---|
| FY 2026 (Un Audited) | 32.10 |
| FY 2025 | 64.08 |
| FY 2024 | 14.38 |
Strategic Rationale
The acquisition aligns with Astral's strategy of investing in technology-led capabilities. DSS is noted for being the only entity in India possessing technology to produce a wide range of Polyamines and unique Bismaleimides and Benzoxazines. These products are critical for the adhesives, paints, and construction chemicals sectors. By integrating DSS, Astral aims to leverage these proprietary technologies to enhance its research and development capabilities and facilitate entry into high-value B2B markets such as electronics and aerospace.
Management Commentary
Commenting on the development, Mr. Saumya Engineer, CEO - Adhesives and Paints Business of Astral Limited, stated that the acquisition will strengthen the company's technology platform and deepen backward integration across critical specialty chemistries. He highlighted that the addition of advanced specialty chemicals would enable greater innovation across adhesives, paints, and construction chemicals while reinforcing resilience across the value chain.
Historical Stock Returns for Astral
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.23% | -2.63% | -4.04% | +7.24% | -1.11% | +3.96% |
What are the specific capital expenditure plans to scale DSS's manufacturing capacity beyond the current 5,200 M.T.?
How will the recent decline in DSS's turnover from FY 2025 to FY 2026 be addressed prior to the deal's closure in 2026?
What is the expected timeline for monetizing DSS’s proprietary technologies in the high-value aerospace and electronics B2B markets?
Create Custom Screeners 
Access 200+ Pre-built Filters 
Use 50+ Readymade Screener 
